TALPHERA, INC. Current Assets
TALPHERA, INC. (TLPH) had Current Assets of $17.99 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-12
- 2026-06-30: Assets, Current $17.99M.
- 2026-03-31: Assets, Current $21.34M.
- 2025-12-31: Assets, Current $20.90M.
- 2025-09-30: Assets, Current $21.92M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $17.99M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $21.34M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $20.90M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $21.92M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $7.70M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.18M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $9.42M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $12.20M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $16.04M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $19.95M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $11.58M 10-K · filed 2025-03-31 | $11.56M 10-K · filed 2024-03-06 |
| 2023-09-30 | $14.42M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.84M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $17.35M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $24.57M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $24.54M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $32.00M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $42.81M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $50.49M 8-K · filed 2023-08-01 | $55.49M 10-K · filed 2022-03-10 |
| 2021-09-30 | $51.75M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $58.97M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $71.31M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $46.83M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $47.80M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $48.62M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $58.05M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $71.69M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $85.67M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $96.82M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $95.34M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $107.99M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $66.00M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $52.96M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $53.66M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $63.41M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $71.07M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $66.77M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $77.97M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $89.05M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $96.92M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $105.55M 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $112.79M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $118.95M 10-K · filed 2017-03-03 | |
| 2015-09-30 | $122.59M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $53.52M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $65.42M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $76.30M 10-K · filed 2016-03-07 | |
| 2014-09-30 | $86.64M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $93.22M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $93.97M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $104.56M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $77.00M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $35.23M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $50.33M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $61.77M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $25.30M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $33.69M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $31.07M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $38.15M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $34.08M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $39.01M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | $5.78M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |